Abstract:Abstract Background Intrauterine exposure to a disturbed maternal glucose metabolism is associated with adverse offspring outcomes. DNA methylation is a potential mechanism underlying these associations. We examined whether maternal early-pregnancy glucose and insulin concentrations are associated with newborn DNA methylation. In a population-based prospective cohort study among 935 pregnant women, maternal plasma concentrations of non-fasting glucose and insulin were measured at a median of 13.1 weeks of gestation (95% range 9.4–17.4). DNA methylation was measured using the Infinium HumanMethylation450 BeadChip (Ilumina). We analyzed associations of maternal early-pregnancy glucose and insulin concentrations with single-CpG DNA methylation using robust linear regression models. Differentially methylated regions were analyzed using the dmrff package in R. We stratified the analyses on normal weight versus overweight or obese women. We also performed a look-up of CpGs and differently methylated regions from previous studies to be associated with maternal gestational diabetes, hyperglycemia or hyperinsulinemia, or with type 2 diabetes in adults. Results Maternal early-pregnancy glucose and insulin concentrations were not associated with DNA methylation at single CpGs nor with differentially methylated regions in the total group. In analyses stratified on maternal BMI, maternal early-pregnancy glucose concentrations were associated with DNA methylation at one CpG (cg03617420, XKR6 ) among normal weight women and at another (cg12081946, IL17D ) among overweight or obese women. No stratum-specific associations were found for maternal early-pregnancy insulin concentrations. The two CpGs were not associated with birth weight or childhood glycemic measures ( p values > 0.1). Maternal early-pregnancy insulin concentrations were associated with one CpG known to be related to adult type 2 diabetes. Enrichment among nominally significant findings in our maternal early-pregnancy glucose concentrations was found for CpGs identified in a previous study on adult type 2 diabetes. Conclusions Maternal early-pregnancy glucose concentrations, but not insulin concentrations, were associated with DNA methylation at one CpG each in the subgroups of normal weight and of overweight or obese women. No associations were present in the full group. The role of these CpGs in mechanisms underlying offspring health outcomes needs further study. Future studies should replicate our results in larger samples with early-pregnancy information on maternal fasting glucose metabolism.

DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes

Genome-wide DNA Methylation Profiling in Infants Born to Gestational Diabetes Mellitus

Differential Methylation of Genes in Individuals Exposed to Maternal Diabetes in Utero

DNA methylation links genetics, fetal environment, and an unhealthy lifestyle to the development of type 2 diabetes

DNA methylation trajectories and accelerated epigenetic aging in incident type 2 diabetes

Novel epigenetic determinants of type 2 diabetes in Mexican-American families

DNA methylation risk score for type 2 diabetes is associated with gestational diabetes

Increased Methylation at Differentially Methylated Region of GNASin Infants Born to Gestational Diabetes

Epigenetics of the non-coding RNA nc886 across blood, adipose tissue and skeletal muscle in offspring exposed to diabetes in pregnancy

Maternal DNA methylation signatures of arsenic exposure is associated with adult offspring insulin resistance in the Strong Heart Study

Genetic architecture and biology of youth-onset type 2 diabetes

Epigenetic Profiling of Type 2 Diabetes Mellitus: An Epigenome-Wide Association Study of DNA Methylation in the Korean Genome and Epidemiology Study

The effect of environmental factors and DNA methylation on type 2 diabetes mellitus]

Blood DNA Methylation and Type 2 Diabetes Mellitus

Association of DNA Methylation with Infant Birth Weight in Women with Gestational Diabetes

Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes

Exploring early DNA methylation alterations in type 1 diabetes: implications of glycemic control

DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes

Associations of maternal early-pregnancy blood glucose and insulin concentrations with DNA methylation in newborns

A Longitudinal Study of DNA Methylation As a Potential Mediator of Age-Related Diabetes Risk

DNA methylation and gene expression analysis in adipose tissue to identify new loci associated with T2D development in obesity